عبدالله . ن. . (2022). Evaluation of the efficacy of bevacizumab in recurrence metastatic ovarian cancer as a second-line and beyond. Tishreen University Journal -Medical Sciences Series, 44(1), 49–57. Retrieved from https://journal.tishreen.edu.sy/index.php/hlthscnc/article/view/12000